Jeffrey S. Hackman Fennec Pharmaceuticals Inc. (FENC) insider trading activity

Jeffrey S. Hackman is Chief Executive Officer of FENNEC PHARMACEUTICALS INC.. Currently has a direct ownership of 15,000 shares of FENC, which is worth approximately $123,300. The most recent transaction as insider was on May 19, 2025, when has been sold 13,965 shares (Common Shares) at a price of $6.99 per share, resulting in proceeds of $97,615. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 15K

0% 3M change

n/a 12M change

Total Value Held $123,300

Jeffrey S. Hackman Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
May 19 2025	BUY Open market or private purchase	$97,615 $6.99 p/Share	13,965 Added 48.21%	15,000 Common Shares
May 16 2025	BUY Open market or private purchase	$6,986 $6.75 p/Share	1,035 Added 50.0%	1,035 Common Shares

Also insider at

CMRA

Comera Life Sciences Holdings, Inc. Healthcare

Director

JSH